CNA.L

Centrica Plc
Centrica PLC - Transaction in Own Shares
12th June 2025, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4793M
Centrica PLC
12 June 2025
 

Transactions in own shares

 

Centrica plc

12 June 2025

 

Centrica plc announces that it purchased on 11 June 2025 (through Merrill Lynch International) 2,571,065 Centrica plc ordinary shares of 6 14/81 pence each at a price of 163.99 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the extension of the Company's 2024-25 buyback programme announced on 27 December 2024 and in accordance with the non-discretionary share repurchase agreement entered into with Merrill Lynch International as also announced on 27 December 2024, which agreement was subsequently amended as announced on 3 March 2025.

 

Since 3 March 2025, Centrica has purchased 170,087,788 ordinary shares at a cost (excluding dealing and associated costs) of £261,088,808.99.

 

Following the above purchase, Centrica plc holds 513,792,560 ordinary shares in treasury, and has 4,904,314,654 ordinary shares in issue (excluding treasury shares).

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Merrill Lynch International is set out below.

 

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

 

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

Merrill Lynch International

Intermediary Code:

MLILGB3LESF

Currency:

GBP

 

Aggregated information

Date of purchase:

11 June 2025

Number of ordinary shares purchased:

2,571,065

Highest price paid:

164.80p

Lowest price paid:

163.40p

Volume weighted average price paid per share:

163.99p

 

Disaggregated information

 

The table attached contains detailed information of the individual trades made by Merrill Lynch International, as part of the buyback programme.

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

 http://www.rns-pdf.londonstockexchange.com/rns/4793M_1-2025-6-11.pdf

END

 

Enquiries:

Investors and Analysts

E: ir@centrica.com

 

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMZGMVNMMGKZM]]>
TwitterFacebookLinkedIn